ClinicalTrials.govpublic full text
A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants
covid19, sars-cov-2 coronavirus, coronavirus disease 2019, covid-19, japanese pharmacokinetics, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 887754
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.